These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30240587)

  • 1. RNA interference to enhance radiation therapy: Targeting the DNA damage response.
    Ratnayake G; Bain AL; Fletcher N; Howard CB; Khanna KK; Thurecht KJ
    Cancer Lett; 2018 Dec; 439():14-23. PubMed ID: 30240587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical issues in delivery of RNAi therapeutics in vivo.
    Rivera S; Yuan F
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1279-91. PubMed ID: 22201583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi therapeutics and applications of microRNAs in cancer treatment.
    Uchino K; Ochiya T; Takeshita F
    Jpn J Clin Oncol; 2013 Jun; 43(6):596-607. PubMed ID: 23592885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes.
    Mizrahy S; Hazan-Halevy I; Dammes N; Landesman-Milo D; Peer D
    Mol Ther; 2017 Jul; 25(7):1491-1500. PubMed ID: 28392163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of RNAi nanomedicines.
    Barros SA; Gollob JA
    Adv Drug Deliv Rev; 2012 Dec; 64(15):1730-7. PubMed ID: 22732527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. siRNA delivery systems for cancer treatment.
    Oh YK; Park TG
    Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on RNA interference-mediated gene silencing in cancer therapy.
    Ren YJ; Zhang Y
    Expert Opin Biol Ther; 2014 Nov; 14(11):1581-92. PubMed ID: 25010067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNAi-based nanomedicines for targeted personalized therapy.
    Daka A; Peer D
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1508-21. PubMed ID: 22975009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
    DeVincenzo JP
    Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.
    Sajeesh S; Lee TY; Kim JK; Son DS; Hong SW; Kim S; Yun WS; Kim S; Chang C; Li C; Lee DK
    J Control Release; 2014 Dec; 196():28-36. PubMed ID: 25251899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation.
    Fujimori H; Sato A; Kikuhara S; Wang J; Hirai T; Sasaki Y; Murakami Y; Okayasu R; Masutani M
    Sci Rep; 2015 Dec; 5():18231. PubMed ID: 26667181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in siRNA delivery in cancer therapy.
    Singh A; Trivedi P; Jain NK
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference (RNAi)-based plasmonic nanomaterials for cancer diagnosis and therapy.
    Yoon J; Shin M; Lee JY; Lee SN; Choi JH; Choi JW
    J Control Release; 2022 Feb; 342():228-240. PubMed ID: 35016917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-siRNA: A potential cancer therapy?
    Young SW; Stenzel M; Yang JL
    Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral delivery of RNA interference targeting cancer cells in cancer gene therapy.
    Huang PI; Lo WL; Cherng JY; Chien Y; Chiou GY; Chiou SH
    Curr Gene Ther; 2012 Aug; 12(4):275-84. PubMed ID: 22856602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects of RNA interference therapy for cancer.
    Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
    Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference-based therapy and its delivery systems.
    Chen X; Mangala LS; Rodriguez-Aguayo C; Kong X; Lopez-Berestein G; Sood AK
    Cancer Metastasis Rev; 2018 Mar; 37(1):107-124. PubMed ID: 29243000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment.
    Ward DM; Shodeinde AB; Peppas NA
    Adv Healthc Mater; 2021 Jul; 10(13):e2100350. PubMed ID: 33973393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.